Literature DB >> 19653879

Association of apolipoprotein E and angiotensin converting enzyme gene polymorphisms with the multidimensional impairment in older patients.

Alberto Pilotto1, Maria G Matera, Luigi Ferrucci, Daniele Sancarlo, Gioacchino Leandro, Grazia D'Onofrio, Davide Seripa, Filomena Addante, Marilisa Franceschi, Bruno Dallapiccola.   

Abstract

The role of the apolipoprotein E (APOE) and the angiotensin converting enzyme (ACE) polymorphisms on health and functional status deterioration in old age is still undefined. Recently, a Multidimensional Prognostic Index (MPI) for 1-year mortality derived from a Comprehensive Geriatric Assessment (CGA) was developed and validated in hospitalized elderly patients. The aim of this study was to investigate the possible association of the APOE and ACE gene polymorphisms with the multidimensional impairment, as evaluated by the MPI, in older patients. These polymorphisms were assessed in 1894 geriatric inpatients divided into three groups according to their MPI values: MPI-1 low risk (n = 988), MPI-2 moderate risk (n = 671), and MPI-3 severe risk of mortality (n = 235). A slight deviation from Hardy-Weinberg equilibrium was observed for the APOE genotypes. With the increasing of the MPI grade, a significant increase in the frequencies of epsilon4 allele and the ACE D/D genotype was observed. The APOE epsilon4(+) and ACE D/D genotypes were associated with severe MPI grade (APOE epsilon4(+), odds ration [OR] = 1.79, 95% confidence interval [CI] 1.20-2.67; ACE D/D, OR = 1.42, 95% CI 1.05-1.92). The combined APOE epsilon4(+) and ACE D/D genetic status was associated with higher MPI grade (OR = 2.85, 95% CI 1.75-4.65), without interaction. No significant associations between APOE and ACE polymorphisms and 2-year mortality were found. APOE and ACE genes might predispose individuals to health and functional status deterioration in old age, and their effect is additive.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19653879      PMCID: PMC2868322          DOI: 10.1089/rej.2009.0858

Source DB:  PubMed          Journal:  Rejuvenation Res        ISSN: 1549-1684            Impact factor:   4.663


  31 in total

1.  Evaluation of the interactions of common genetic mutations in stroke subtypes.

Authors:  Zoltán Szolnoki; Ferenc Somogyvári; András Kondacs; Mihály Szabó; Lajos Fodor
Journal:  J Neurol       Date:  2002-10       Impact factor: 4.849

2.  Estimation of apolipoprotein E genotype-specific relative mortality risks from the distribution of genotypes in centenarians and middle-aged men: apolipoprotein E gene is a "frailty gene," not a "longevity gene".

Authors:  L U Gerdes; B Jeune; K A Ranberg; H Nybo; J W Vaupel
Journal:  Genet Epidemiol       Date:  2000-10       Impact factor: 2.135

3.  Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability.

Authors:  Ian Janssen; Steven B Heymsfield; Robert Ross
Journal:  J Am Geriatr Soc       Date:  2002-05       Impact factor: 5.562

4.  Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation.

Authors:  T Vogel; N H Guo; R Guy; N Drezlich; H C Krutzsch; D A Blake; A Panet; D D Roberts
Journal:  J Cell Biochem       Date:  1994-03       Impact factor: 4.429

5.  Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world.

Authors:  L U Gerdes; I C Klausen; I Sihm; O Faergeman
Journal:  Genet Epidemiol       Date:  1992       Impact factor: 2.135

6.  Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease.

Authors:  Yiqing Song; Meir J Stampfer; Simin Liu
Journal:  Ann Intern Med       Date:  2004-07-20       Impact factor: 25.391

Review 7.  Vascular genetic factors and human longevity.

Authors:  Francesco Panza; Alessia D'Introno; Anna M Colacicco; Cristiano Capurso; Sabrina Capurso; Patrick G Kehoe; Antonio Capurso; Vincenzo Solfrizzi
Journal:  Mech Ageing Dev       Date:  2004-03       Impact factor: 5.432

8.  Methylenetetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms in two genetically and diagnostically distinct cohort of Alzheimer patients.

Authors:  Davide Seripa; Gloria Dal Forno; Maria G Matera; Carolina Gravina; Maurizio Margaglione; Mark T Palermo; David R Wekstein; Piero Antuono; Daron G Davis; Antonio Daniele; Carlo Masullo; Alessandra Bizzarro; Massimo Gennarelli; Vito M Fazio
Journal:  Neurobiol Aging       Date:  2003-11       Impact factor: 4.673

9.  The Multidimensional Prognostic Index (MPI), based on a comprehensive geriatric assessment predicts short- and long-term mortality in hospitalized older patients with dementia.

Authors:  Alberto Pilotto; Daniele Sancarlo; Francesco Panza; Francesco Paris; Grazia D'Onofrio; Leandro Cascavilla; Filomena Addante; Davide Seripa; Vincenzo Solfrizzi; Bruno Dallapiccola; Marilisa Franceschi; Luigi Ferrucci
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

10.  Angiotensin I converting enzyme (ACE) gene polymorphism in centenarians: different allele frequencies between the North and South of Europe.

Authors:  Francesco Panza; Vincenzo Solfrizzi; Alessia D'Introno; Anna Maria Colacicco; Cristiano Capurso; Patrick G Kehoe; Antonio Capurso
Journal:  Exp Gerontol       Date:  2003-09       Impact factor: 4.032

View more
  2 in total

1.  Angiotensin-converting enzyme (ACE) genotypes and disability in hospitalized older patients.

Authors:  Davide Seripa; Giulia Paroni; Maria G Matera; Carolina Gravina; Carlo Scarcelli; Michele Corritore; Luigi P D'Ambrosio; Maria Urbano; Grazia D'Onofrio; Massimiliano Copetti; Patrick G Kehoe; Francesco Panza; Alberto Pilotto
Journal:  Age (Dordr)       Date:  2010-11-13

2.  Apolipoprotein E-related all-cause mortality in hospitalized elderly patients.

Authors:  Maria G Matera; Daniele Sancarlo; Francesco Panza; Carolina Gravina; Grazia D'Onofrio; Vincenza Frisardi; Grazia Longo; Luigi P D'Ambrosio; Filomena Addante; Massimiliano Copetti; Vincenzo Solfrizzi; Davide Seripa; Alberto Pilotto
Journal:  Age (Dordr)       Date:  2010-04-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.